Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. We have achieved this goal since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel’s productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as ( www.rigel.com )
Rigel Pharmaceuticals , Inc.
1180 Veterans Boulevard
South San Francisco, California 94080
USA
Tel: (650) 624-1100
Fax: (650) 624-1101